Clinical Trial Update: Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pembrolizumab in locally advanced esophageal adenocarcinoma has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Esophageal Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-05-02